To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer

Summary

The aim of this study is to evaluate the efficacy and safety of i.v. infusion for 24-hour of SCB01A in subjects with squamous cell carcinoma of head and neck who have failed previous platinum based therapies.

Timeline

Start

2017-04-30

Primary completion

2018-11-20

Completion

2018-11-20

Outcome

Outcome not reported

Stopped: “withdrawal by sponsor”

Drugs

Indications